The importance of treating the field in actinic keratosis
Author:
Affiliation:
1. Klinik für Dermatologie, Venerologie und Allergologie; St. Josef-Hospital; Ruhr-Universität Bochum; Bochum Germany
Publisher
Wiley
Subject
Infectious Diseases,Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.14092/fullpdf
Reference41 articles.
1. Actinic keratosis and field cancerisation;Stockfleth;Eur J Dermatol,2011
2. Actinic keratosis: a clinical and epidemiological revision;Schmitt;An Bras Dermatol,2012
3. Management of actinic keratosis: a practical report and treatment algorithm from AKTeam expert clinicians;Dreno;J Eur Acad Dermatol Venereol,2014
4. The risk of progression to invasive disease;Glogau;J Am Acad Dermatol,2000
5. The majority of cutaneous squamous cell carcinomas arise in actinic keratoses;Czarnecki;J Cutan Med Surg,2002
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Photographic scale for the characterization of actinic keratosis through reflectance confocal microscopy: a quantitative approach to cellular transformation;Frontiers in Medicine;2024-09-04
2. Precision therapy for cancer prevention by targeting carcinogenesis;Molecular Carcinogenesis;2024-08-14
3. Therapeutic and fluorescence evaluation of 20% 5-aminolevulinic acid-mediated photodynamic therapy in actinic keratosis;Photodiagnosis and Photodynamic Therapy;2024-06
4. European consensus‐based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV‐induced dysplasia and field cancerization on behalf of European Association of Dermato‐Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes);Journal of the European Academy of Dermatology and Venereology;2024-03-07
5. Pharmacokinetics, Safety, and Tolerability of a Single 5‐Day Treatment of Tirbanibulin Ointment 1% in 100 cm2: A Phase 1 Maximal‐Use Trial in Patients with Actinic Keratosis;Clinical Pharmacology in Drug Development;2024-01-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3